[17] Recently, the code combination 362.53 (cystoid macular edema) plus 250.xx (diabetes mellitus) was found to have high sensitivity and specificity for DME in a regional study of 22 ...

A recent cohort study revealed low adoption of FDA-approved AI-based diabetic retinopathy detection, with less than 5% of diabetic patients receiving ophthalmic imaging. Researchers emphasize the need ...

Diabetic macular edema can result in low vision or vision loss. Early treatment can help preserve vision longer. Diabetic macular edema (DME) is a complication of diabetes. Over time, high blood ...

Intraocular Steroid Injection: Administration of steroids straight into the eye helps minimize swelling and scar tissue development in the eyes of patients suffering from diabetic retinopathy. This ...

APX-3330 is under development for the treatment of solid tumors including pancreatic ductal adenocarcinoma, pancreatic ductal adenocarcinoma, endometrial cancer, melanoma, prostate cancer and ...

Since July 2024, faricimab has also been approved in Europe for the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion. The German Institute for Quality and ...

Vision loss occurs in DR due to the development of maculopathy, especially diabetic macular edema, and due to proliferative diabetic retinopathy. Vision loss due to DR is preventable with the ...

Fluocinolone acetonide SR is under clinical development by EyePoint Pharmaceuticals and currently in Phase III for Retinopathy. According to GlobalData ... It is indicated for the treatment of vision ...